Paper Details

  1. Home
  2. Paper Details

The return to the USA of doxylamine-pyridoxine delayed release combination (Diclegis®) for morning sickness--a new morning for American women.

Author: KorenGideon

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

The US FDA approval of Diclegis®, a doxylamine-pyridoxine combination for morning sickness, is a major milestone in treating this common medical condition in pregnancy.
Paper Details　
Original Abstract of the Article :
The US FDA approval in April 2013 of Diclegis®, the doxylamine-pyridoxine combination for morning sickness, is a major milestone, particularly since it is indicated for use in pregnancy and the FDA has labeled it a pregnancy category A drug the strongest evidence of fetal safety. After thirty years ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/23863487

データ提供：米国国立医学図書館（NLM）

Diclegis® for Morning Sickness: A New Dawn for American Women

Morning sickness is a common experience during pregnancy, often described as a relentless desert storm that disrupts the journey to motherhood. For decades, American women have faced a lack of safe and effective treatment options, leaving them feeling stranded in the desert of discomfort. This study explores the return of Diclegis®, a combination of doxylamine and pyridoxine, as a potential oasis in the desert of morning sickness.

A New Solution for Morning Sickness

The study celebrates the FDA's approval of Diclegis® for the treatment of morning sickness, a welcome relief for pregnant women seeking relief from this common ailment. It's like discovering a new source of water in the desert, providing much-needed hydration and comfort. The researchers emphasize the drug's safety profile, offering a safe and effective solution for millions of women.

Navigating Pregnancy with Confidence

This study offers a beacon of hope for pregnant women facing the challenges of morning sickness. It's like finding a trusted guide who can help navigate the treacherous terrain of pregnancy with confidence and ease. With the availability of Diclegis®, women can now focus on enjoying their journey to motherhood, knowing that they have a reliable solution for managing morning sickness.

Dr.Camel's Conclusion

This study marks a significant milestone in the fight against morning sickness, providing a safe and effective treatment option for pregnant women in the United States. It's a reminder that even in the vast and unpredictable desert of pregnancy, innovation and perseverance can lead to solutions that improve the lives of countless people.
Date :
  1. Date Completed 2013-12-04
  2. Date Revised 2020-02-19
Further Info :

Pubmed ID

23863487

DOI: Digital Object Identifier

23863487

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.